Doured Daghistani, MD

 

Odia, Y., Koschmann, C., ..., Daghistani, D., et al (2024). Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3K27M-mutant glioma. Neuro-oncology, Ahead of print(), . View in Pubmed

Venneti, S., Kawakibi, A.R., ..., Daghistani, D., et al (2023). Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways. Neuro-oncology Advances, 13(11), 2370-2393. View in Pubmed

Gardner, S.L., Tarapore, R.S., ..., Daghistani, D., et al (2022). Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy. Neuro-oncology Advances, 4(1), vdac143. View in Pubmed

Primary Office

Address:
Kidz Medical Services, Inc.
8900 N Kendall Drive - MCI
Miami, FL 33176
Phone Number:
305-274-1662

Additional Office

Address:
Kidz Medical Services, Inc.
3100 SW 62 Avenue -NE Wing #121
Miami, FL 33155
Phone Number:
305-662-8360

Education

Fellowship - Jackson Memorial Hospital
Residency - Jackson Memorial Hospital
Medical School - Damascus University

Board Certifications

American Board of Pediatrics (Pediatrics) - Certified
American Board of Pediatrics (Ped Hemat-Onc) - Certified